DocGo Inc 2026年季度报告

FORM 10-Q (Mark One)QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2026 OR For the transition period from to (Registrant’s Telephone Number, Including Area Code) N/A(Former Name, Former Address and Former Fiscal Year, If Changed Since Last Report) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2) has been subject to such filing requirements for the past 90 days. YesNo Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files). YesNo Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smallerreporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YesNo As of August14, 2026, 98,928,369 shares of the registrant’s common stock, par value $0.0001 per share, were issued and outstanding. Table of Contents PagePART I - FINANCIAL INFORMATIONItem 1. Financial Statements2Item 2. Management’s Discussion and Analysis of Financial Condition and Result of Operations46Item 3. Quantitative and Qualitative Disclosures About Market Risk65Item 4. Controls and Procedures66PART II - OTHER INFORMATIONItem 1. Legal Proceedings67Item 1A. Risk Factors67Item 2. Unregistered Sales of Equity Securities and Use of Proceeds67Item 3. Defaults Upon Senior Securities67Item 4. Mine Safety Disclosures67Item 5. Other Information68Item 6. Exhibits68Signatures69 PART I. FINANCIAL INFORMATION Condensed Consolidated Balance Sheets as of June 30, 2026 (Unaudited) and December 31, 20252Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three and SixMonths Ended June 30, 2026 and 20253Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Three and Six MonthsEnded June 30, 2026 and 20254Unaudited Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2026 and 20255Notes to Unaudited Condensed Consolidated Financial Statements7 DocGo Inc. and Subsidiaries UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements. DocGo Inc. and Subsidiaries UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS DocGo Inc. and Subsidiaries UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(CONTINUED) NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 1. Description of Organization and Business Operations Background On November 5, 2021, DocGo Inc., a Delaware corporation, then known as Motion Acquisition Corp. (collectively with itssubsidiaries, the “Company”), consummated a business combination pursuant to that certain Agreement and Plan of Merger, datedMarch 8, 2021 (the “Merger Agreement”), by and among the Company, Motion Merger Sub Corp., a Delaware corporation and adirect wholly owned subsidiary of the Company (“Merger Sub”), and Ambulnz, Inc., a Delaware corporation (“Ambulnz”). Thetransactions contemplated by the Merger Agreement are referred to herein as the “Business Combination.” In connection with theclosing of the Business Combination, the Company changed its name from Motion Acquisition Corp. to DocGo Inc. Pursuant to the Merger Agreement and as described in the Company’s definitive proxy statement/consent solicitation/prospectus filedwith the U.S. Securities and Exchange Commission (the “SEC”) on October 14, 2021, Merger Sub merged with and into Ambulnz,with Ambulnz continuing as the surviving corporation and becoming a wholly owned subsidiary of the Company. Ambulnz was originally formed in Delaware on June 17, 2015 as Ambulnz, LLC, a limited liability company. On November 1, 2017,with an effective date of January 1, 2017, Ambulnz converted its legal structure from a limited liability company to a C-corporationand changed its name to Ambulnz, Inc. Ambulnz is the sole owner of Ambulnz Holdings, LLC (“Holdings”), which wa